SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
🔥 科研通第二届『
应助活动周
』正在进行中,3月24-30日求助秒级响应🚀,千元现金等你拿。
当前排名🏆
📚 中科院2025期刊分区📊 已更新
劲爆巧克力
Lv5
1560 积分
2022-05-06 加入
最近求助
最近应助
互助留言
Opioid switching and rotation in primary care: implementation and clinical utility
18天前
已完结
LncRNA SNHG1 enhances cartilage regeneration by modulating chondrogenic differentiation and angiogenesis potentials of JBMMSCs via mitochondrial function regulation
1个月前
已完结
Advancements in modifying the efficacy of immunotherapies through the thermal effects of nanomaterials
2个月前
已完结
Two-dimensional nano-biomaterials in regulating the tumor microenvironment for immunotherapy
2个月前
已完结
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study
3个月前
已完结
Fluctuations in routine blood count might signal severe immune-related adverse events in melanoma patients treated with nivolumab
3个月前
已完结
Nivolumab in patients with advanced hepatocellular carcinoma and Child‐Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series
3个月前
已完结
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
3个月前
已完结
Updated Efficacy Analysis Including Secondary Population Results for OAK: A Randomized Phase III Study of Atezolizumab versus Docetaxel in Patients with Previously Treated Advanced Non–Small Cell Lung Cancer
3个月前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
3个月前
已完结
没有进行任何应助
信息错误【积分已退回】
4个月前
找到了【积分已退回】
6个月前
感谢
2年前
感谢
2年前
感谢
2年前
速度真快,感谢
2年前
感谢
2年前
感谢
2年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论